<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0025">
 <label>25</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Beaver</surname>
    <given-names>JA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Amiri-Kordestani</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Charlab</surname>
    <given-names>R</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer</article-title>. 
  <source>Clin Cancer Res</source>
  <year>2015</year>;
  <volume>21</volume>:
  <fpage>4760</fpage>–
  <lpage>6</lpage>.
  <pub-id pub-id-type="pmid">26324739</pub-id>
 </mixed-citation>
</ref>
